(Press-News.org)
Researchers from King’s, with doctors at King’s College Hospital NHS Foundation Trust, have successfully used a new robot system to improve treatment for debilitating eye disease.
The custom-built robot was used to treat wet neovascular age-related macular degeneration (AMD), administering a one-off, minimally invasive dose of radiation, followed by patients’ routine treatment with injections into their eye.
In the landmark trial, published today in The Lancet, it was found that patients then needed fewer injections to effectively control the disease, potentially saving around 1.8 million injections per year around the world.
Wet AMD is a debilitating eye disease, where abnormal new blood vessels grow into the macula, the light sensing-layer of cells inside the back of the eyeball. The vessels then start to leak blood and fluid, typically causing a rapid, permanent and severe loss of sight.
Globally, around 196 million people have AMD and the Royal College of Ophthalmologists estimates that the disease affects more than 700,000 people in the UK. The number of people with AMD is expected to increase 60% by 2035, due to the country’s ageing population.
Wet AMD is currently treated with regular injections into the eye. Initially, treatment substantially improves a patient’s vision. But, because the injections don’t cure the disease, fluid will eventually start to build up again in the macula, and patients will require long-term, repeated injections. Most people require an injection around every 1-3 months, and eye injections, costing between £500 and £800 per injection, have become one of the most common NHS procedures.
The new treatment can be targeted far better than existing methods, aiming three beams of highly focused radiation into the diseased eye. Scientists found that patients having robotic radiotherapy required fewer injections to control their disease compared to standard treatment.
The study found that the robotically controlled device saves the NHS £565 for each patient treated over the first two years, as it results in fewer injections.
The study lead and first author on the paper, Professor Timothy Jackson, King’s College London and Consultant Ophthalmic Surgeon at King’s College Hospital said: “Research has previously tried to find a better way to target radiotherapy to the macula, such as by repurposing devices used to treat brain tumours. But so far nothing has been sufficiently precise to target macular disease that may be less than 1 mm across.
“With this purpose-built robotic system, we can be incredibly precise, using overlapping beams of radiation to treat a very small lesion in the back of the eye.
“Patients generally accept that they need to have eye injections to help preserve their vision, but frequent hospital attendance and repeated eye injections isn’t something they enjoy. By better stabilising the disease and reducing its activity, the new treatment could reduce the number of injections people need by about a quarter. Hopefully, this discovery will reduce the burden of treatment that patients have to endure.”
Dr Helen Dakin, University Research Lecturer at the University of Oxford said: “We found that the savings from giving fewer injections are larger than the cost of robot-controlled radiotherapy. This new treatment can therefore save the NHS money that can be used to treat other patients, while controlling patients’ AMD just as well as standard care.”
The research was jointly funded by the National Institute for Health and Care Research (NIHR) and the Medical Research Council (MRC) and recruited 411 participants across 30 NHS hospitals. A Lancet-commissioned commentary that accompanied the article described it as a “landmark trial”.
This study was led by researchers from King’s College London and doctors at King’s College Hospital NHS Foundation Trust, in collaboration with the University of Oxford, the University of Bristol and Queen’s University in Belfast.
The research can be viewed via this link https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00687-1/fulltext in The Lancet.
ENDS
For more information, please contact comms@kcl.ac.uk at King’s College London
END
Robot radiotherapy could improve treatments for eye disease
2024-06-12
ELSE PRESS RELEASES FROM THIS DATE:
Millions of insects migrate through 30-metre Pyrenees pass
2024-06-12
Over 17 million insects migrate each year through a single mountain pass on the border between France and Spain, new research shows.
University of Exeter scientists studied migrating insects in the Pass of Bujaruelo, a 30-metre gap between two high peaks in the Pyrenees.
The team visited the pass each autumn for four years, monitoring the vast number and variety of day-flying insects heading south.
The findings for this single pass suggest that billions of insects cross the Pyrenees each year, making it a key location for many migrating species.
The migrating insects ...
Should celebrities and influencers turn off their social media comments? A new study suggests they are less persuasive and likable when they do
2024-06-12
Researchers from University of Alabama and Vanderbilt University published a new Journal of Marketing study that examines the negative consequences that celebrities and influences incur when they disable social media comments.
The study, forthcoming in the Journal of Marketing, is titled “No Comments (From You): Understanding the Interpersonal and Professional Consequences of Disabling Social Media Comments” and is authored by Michelle Daniels and Freeman Wu.
Celebrities and influencers like Addison Rae, Hailey Bieber, ...
Painful truth about knee osteoarthritis: Why inactivity may be more complex than we think
2024-06-12
Knee osteoarthritis (OA) is a common cause of pain and joint stiffness. And while physical activity is known to ease symptoms, only one in 10 people regularly exercise.
Understanding what contributes to patients’ inactivity is the focus of a world first study from the University of South Australia. Here, researchers have found that people with knee OA unconsciously believe that activity may be dangerous to their condition, despite medical advice telling them otherwise.
The study found that of those surveyed, 69% of people with knee pain had stronger implicit (unconscious) beliefs that exercise ...
New study finds human-caused nitrous oxide emissions grew 40 percent from 1980-2020, greatly accelerating climate change
2024-06-12
Chestnut Hill, Mass. (6/11/24) – Emissions of nitrous oxide – a greenhouse gas more potent than carbon dioxide or methane – continued unabated between 1980 and 2020, a year when more than 10-million metric tons were released into the atmosphere primarily through farming practices, according to a new report by the Global Carbon Project.
Agricultural production accounted for 74 percent of human-driven nitrous oxide emissions in the 2010s – attributed primarily to the use of chemical fertilizers and ...
Study reveals significant increasing nitrous-oxide emissions from human activities, jeopardizing climate goals
2024-06-12
Emissions of nitrous-oxide (N2O) - a potent greenhouse gas - have continued to rise unabated over the past four decades, according to an international team of scientists.
The new report 'Global nitrous oxide budget (1980–2020)' is published in the journal Earth System Science Data. It is the most comprehensive accounting to date of nitrous-oxide emissions from human activities and natural sources.
It was led by researchers from Boston College in the US and involved an international team of scientists including researchers from the University of East Anglia (UEA), UK, under the umbrella of the Global Carbon Project. ...
Virtual reality as a reliable shooting performance-tracking tool
2024-06-11
COLUMBUS, Ohio – Virtual reality technology can do more than teach weaponry skills in law enforcement and military personnel, a new study suggests: It can accurately record shooting performance and reliably track individuals’ progress over time.
In the study of 30 people with a range of experience levels in handling a rifle, researchers at The Ohio State University found that a ballistic simulator captured data on the shooters’ accuracy, decision-making and reaction time – down to the millimeter in distance ...
New study explores the sun’s effects on the skin microbiome – it can create a damaged skin barrier
2024-06-11
The impact of solar radiation on skin has long been understood but what about UV’s effects on our skin's hidden world – its microbiome?
An article from American Society for Photobiology’s journal delved into existing knowledge on solar radiation’s impact on the skin microbiome and proposed innovative sun protection methods that safeguard both skin integrity and microbiome balance.
Experts offered insights into novel sun protection products designed to shield the skin and mitigate the effects of solar ...
States declare May 17 as NEC Awareness Day
2024-06-11
The NEC Society is leading the way toward a world without necrotizing enterocolitis (NEC), a complex and often deadly intestinal disease affecting the most vulnerable infants. By bringing together families and elected officials, the NEC Society is raising the profile of this devastating neonatal disease. States nationwide have championed NEC Awareness Day Resolutions to recognize May 17.
The NEC Society’s families have partnered with elected officials to declare May 17 NEC Awareness Day in California, Colorado, Georgia, Louisiana, New York, Pennsylvania, and Utah, bringing much-needed attention to this leading cause ...
Precision medicine for sepsis in children within reach
2024-06-11
Sepsis – the leading cause of mortality in children around the world – can present with a wide range of signs and symptoms, making a one-size-fits-all treatment strategy ineffective. Pursuing a precision medicine approach for pediatric sepsis, researchers used artificial intelligence to analyze a large set of clinical data and find a distinct group of patients who might respond better to targeted treatments.
These children share clinical characteristics described as PHES, or persistent hypoxemia (abnormally low oxygen ...
New ACAAI position paper examines safety of receiving live vaccines while on dupilumab
2024-06-11
ARLINGTON HEIGHTS, Ill. (June 11, 2024) – A new position paper from the American College of Allergy, Asthma & Immunology (ACAAI) addresses the safety of administering live vaccines to patients who are currently being treated with dupilumab, a biologic therapy for various allergic conditions. The paper, The Use of Vaccines in Patients Receiving Dupilumab: A Systematic Review and Expert Delphi Consensus Recommendation: A Position Paper of the American College of Allergy, Asthma & Immunology, is published online in Annals of Allergy, Asthma & Immunology, ACAAI’s scientific journal. The panel conducting ...